Search This Blog

Wednesday, October 5, 2016

Elanco Animal Health Enters Agreement to Acquire Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio (NYSE:LLY)

Elanco Animal Health Enters Agreement to Acquire Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.